BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 15210580)

  • 1. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K; Takahashi A; Kaneko M; Sugeno H; Hirasawa N; Hong J; Zee O; Ohuchi K
    Life Sci; 2007 Mar; 80(13):1213-20. PubMed ID: 17258775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the eosinophilic differentiation of HL-60 clone 15 cells induced by n-butyrate.
    Ishihara K; Hong J; Zee O; Ohuchi K
    Int Arch Allergy Immunol; 2005; 137 Suppl 1():77-82. PubMed ID: 15947489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil cell lines.
    Ishihara K
    Methods Mol Biol; 2014; 1178():45-51. PubMed ID: 24986606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y; Okisaka S
    Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.
    Chen J; Du C; Kang J; Wang J
    Chem Biol Interact; 2008 Jan; 171(1):26-36. PubMed ID: 17961528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T; Takai N; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism for the decrease in the FIP1L1-PDGFRalpha protein level in EoL-1 cells by histone deacetylase inhibitors.
    Ishihara K; Kaneko M; Kitamura H; Takahashi A; Hong JJ; Seyama T; Iida K; Wada H; Hirasawa N; Ohuchi K
    Int Arch Allergy Immunol; 2008; 146 Suppl 1():7-10. PubMed ID: 18504399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
    Niki T; Rombouts K; De Bleser P; De Smet K; Rogiers V; Schuppan D; Yoshida M; Gabbiani G; Geerts A
    Hepatology; 1999 Mar; 29(3):858-67. PubMed ID: 10051490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors.
    Kaneko M; Ishihara K; Takahashi A; Hong J; Hirasawa N; Zee O; Ohuchi K
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():28-32. PubMed ID: 17541273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors as potential anti-skin cancer agents.
    Saunders N; Dicker A; Popa C; Jones S; Dahler A
    Cancer Res; 1999 Jan; 59(2):399-404. PubMed ID: 9927053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
    Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
    Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic killing of human leukemia cells by antioxidants and trichostatin A.
    Kang J; Chen J; Zhang D; Da W; Ou Y
    Cancer Chemother Pharmacol; 2004 Dec; 54(6):537-45. PubMed ID: 15248029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
    Zhang JS; Wang L; Huang H; Nelson M; Smith DI
    Genes Chromosomes Cancer; 2001 Feb; 30(2):123-35. PubMed ID: 11135429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of adipocyte differentiation by histone deacetylase inhibitors.
    Kim SN; Choi HY; Kim YK
    Arch Pharm Res; 2009 Apr; 32(4):535-41. PubMed ID: 19407971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Im JY; Kim J; Choi WS; Kim HS
    Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin and trichostatin A cooperatively kill human leukemia cells.
    Chen J; Kang JH
    Pharmazie; 2005 Nov; 60(11):856-60. PubMed ID: 16320950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.